US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Neuroscience and Healthcare ETF

31.87

+0.47221.50%

Volume:2K

Turnover:66.81K

Market Cap:6.37M

PE:- -

High:31.87

Open:31.87

Low:31.87

Close:31.39

52wk High:43.01

52wk Low:27.40

Shares:200.00K

Float Shares:200.00K

Volume Ratio:1.62

T/O Rate:1.05%

Dividend:0.32

Dividend Rate:1.00%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

With the World's First Brain-Computer Interface Approval in Hand, How Far Is Neuracle From Profitability?

Scholar Rock Resubmits Apitegromab MAA to EMA for SMA Treatment

Scholar Rock Holding Corporation - Anticipates Chmp Opinion on Apitegromab Maa in H1 2027

THOMSON REUTERS

Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (Maa) to European Medicines Agency (Ema) for Treatment of Children and Adults with Spinal Muscular Atrophy (Sma)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IBRN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":31.865,"timestamp":1791564225222,"preClose":31.3928,"halted":0,"volume":2097,"delay":0,"changeRate":0.01504166560485198,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Trading","change":0.4722,"latestTime":"10-09 13:51:37 EDT","open":31.865,"high":31.865,"low":31.865,"amount":66810.550014,"amplitude":0,"askPrice":32.52,"askSize":100,"bidPrice":31.2,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":31.3928,"sharesOutstanding":150000,"nav":31.865918,"aum":6373183.6,"dividendRate":0.009998,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":31.72,"preClose":31.3928,"latestTime":"16:10 EDT","volume":6,"amount":188.2912,"timestamp":1791490204224,"change":0.3272,"changeRate":0.010423,"amplitude":0},"volumeRatio":1.618861,"impliedVol":0.0879,"impliedVolPercentile":0.5259},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.618861,"shares":200000,"dividePrice":0.3186,"high":31.865,"amplitude":0,"preClose":31.3928,"low":31.865,"week52Low":27.4025,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":31.865,"eps":0,"divideRate":0.009998,"volume":2097,"delay":0,"ttmEps":0,"open":31.865,"prevYearClose":32.3193,"prevWeekClose":32.552,"prevMonthClose":33.265,"prevQuarterClose":33.265,"fiveDayClose":32.552,"twentyDayClose":37.4262,"sixtyDayClose":38.0334},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1150577208","title":"With the World's First Brain-Computer Interface Approval in Hand, How Far Is Neuracle From Profitability?","url":"https://stock-news.laohu8.com/highlight/detail?id=1150577208","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150577208?lang=en_us&edition=fundamental","pubTime":"2026-10-08 21:02","pubTimestamp":1791464577,"startTime":"0","endTime":"0","summary":"On September 29, Neuracle, a leading player in China's brain-computer interface sector, updated its prospectus for a STAR Market IPO. According to the latest financial data disclosed by the company,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673074028","title":"Scholar Rock Resubmits Apitegromab MAA to EMA for SMA Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074028","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673074028?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:05","pubTimestamp":1791461130,"startTime":"0","endTime":"0","summary":"Scholar Rock resubmits apitegromab MAA to EMA for SMA treatmentScholar Rock resubmitted its EMA marketing authorization application for apitegromab to treat children and adults with spinal muscular at","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL87NWDn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SRRK","THNR","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673747750","title":"Scholar Rock Holding Corporation - Anticipates Chmp Opinion on Apitegromab Maa in H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2673747750","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673747750?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUA29VWNX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SRRK","THNR","IBRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673744880","title":"Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (Maa) to European Medicines Agency (Ema) for Treatment of Children and Adults with Spinal Muscular Atrophy (Sma)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673744880","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673744880?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUA29VWNX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THNR","BK4139","SRRK","IBRN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IBRN\",params:#limit:6,delay:false,,,undefined,":[]}}